AstraZeneca
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology corporation specializing in the discovery, development, manufacturing, and commercialization of prescription medications across major therapeutic areas including oncology, cardiovascular, renal, metabolism, respiratory, immunology, and rare diseases. The company operates state-of-the-art research laboratories and global manufacturing facilities, delivering innovative medicines to healthcare systems worldwide. Its core business activities encompass biopharmaceutical research, clinical drug trials, regulatory compliance, and global commercial distribution. Revenue is derived primarily from direct commercial sales of branded prescription pharmaceuticals to wholesalers, pharmacies, and healthcare institutions. AstraZeneca holds a leading global market position in oncology and biopharmaceutical drug manufacturing. The company is headquartered in Cambridge, United Kingdom, and its shares trade on the London Stock Exchange, Nasdaq Stockholm, and the New York Stock Exchange.
256 of the funds FundTelligence covers report a position in AstraZeneca.
- Legal name
- AstraZeneca PLC
- Sector
- Health Care
- Country
- United Kingdom
- Funds holding it
- 256
- Exposure themes
- Multiple, Treatment, Women's Health
Funds holding AstraZeneca
- BlackRock iShares MSCI Europe Health Care Sector UCITS ETF — BlackRock · 14.26 % (full portfolio disclosed, October 2026)
- C WorldWide Healthcare Select — C WorldWide · 9.8 % (largest positions only, October 2026)
- BGF United Kingdom Fund — BlackRock · 8.35 % (largest positions only, September 2026)
- iShares UK Index Fund (IE) — BlackRock · 8.0 % (largest positions only, September 2026)
- BNP Health Care Innovators — BNP Paribas · 7.37 % (full portfolio disclosed, June 2026)
- DNB Health Care — DNB · 7.11 % (full portfolio disclosed, September 2026)
- UBS Sustainable Health Transformation Equity Fund — UBS · 6.4 % (largest positions only, September 2026)
- Arctic Aurora LifeScience — Arctic · 6.4 % (largest positions only, October 2026)
Showing the 8 largest of 256 funds holding it.